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Background: Ocular sebaceous carcinoma is an uncommon, aggressive ocular neoplasm with potential for regional
and distant metastasis.
Case presentation: A 77-year-old woman was found to have a solitary pulmonary lesion 6 years after the initial
treatment of sebaceous carcinoma of the eyelid. Video-assisted lung wedge resection of an undetermined pulmonary
nodule was carried out successfully. Microscopically, the tumor showed foamy cytoplasm and atypical nuclei, consistent
with metastasis of eyelid sebaceous carcinoma.
Conclusion: This is the first case report of resected solitary pulmonary metastasis of eyelid sebaceous carcinoma.
Pulmonary resection is a good option for the treatment and diagnosis of metastatic eyelid sebaceous carcinoma.
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Sebaceous carcinoma of the eyelid is a relatively rare
malignant tumor, and accounts for less than 1% of all
eyelid tumors [1]. As well as being a rare tumor, seba-
ceous carcinoma can mimic other benign inflammatory
and malignant processes, thus errors or delays in diag-
nosis are not unusual [2-5]. Although local management
strategies for this tumor have previously been described
[6-10], very few reports have focused on the patterns of
metastasis of this tumor and the treatment strategies for
such metastases [7,8]. Here, we report a case of solitary
lung metastasis of eyelid sebaceous carcinoma, and dis-
cuss the clinical implication of surgery for a solitary pul-
monary metastasis from sebaceous carcinoma.
Case presentation
A 77-year-old woman underwent left upper lid resection
in April 2006 for sebaceous carcinoma of the eyelid. The
surgical margin was negative for cancer cells. In January* Correspondence: t-oh@remus.dti.ne.jp
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eyelid, and underwent radiotherapy with a total dose of
57.6 Gy of proton beam therapy followed by orbital ex-
enteration of the left eye [11,12]. In July 2012, positron
emission tomography–computed tomography (PET-CT)
revealed a solitary pulmonary nodule 0.5 cm in size in
the right upper lobe of the patient’s lung, which had
increased to 1.1 cm by September 2013 (Figure 1A).
PET-CT revealed a focus of increased uptake in that
nodule, with a standardized uptake value of 3.7 (Figure 1B).
There was no evidence of other metastatic disease on
PET-CT scans. In September 2013, the patient underwent
video-assisted thoracoscopic wedge resection of the pul-
monary nodule. Frozen sections using oil red O stain revealed
accentuation of lipid and presences of foamy cytoplasm in
tumor cells, which was positive for lipid staining (Figure 2).
Permanent histology demonstrated tumor cells with
foamy cytoplasm and atypical nuclei, accompanying nu-
merous lipid globules within the cytoplasm (Figure 3),
consistent with metastasis of eyelid sebaceous carcinoma.
At the last follow-up, 7 months after resection, there was
no loco-regional recurrence or distant metastasis of the
tumor after surgery.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Computed tomography (CT) and positron emission
tomography of the tumors. (A) Chest CT showed a 1.1 cm nodule
in the anterior segment of the right upper lobe (arrow). (B) PET-CT
showed fluorodeoxyglucose accumulation with a Standardized
uptake value (SUV) of 3.7 (arrowhead).
Figure 2 Accentuation of lipid by staining. The lipid globules
have a red color (frozen sections, oil red O, magnification × 100).
Figure 3 Sebaceous carcinoma cells. Foamy and frothy cytoplasm
and atypical nuclei, occurred with numerous lipid globules within
the cytoplasm of the tumors cells, seen as clear spaces (hematoxylin
and eosin, magnification × 100).
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Sebaceous carcinoma of the eyelid refers to a group of
carcinomas derived from sebaceous gland cells that occur
in the ocular adnexa. It can be invasive in the eyelid and
conjunctiva, and can metastasize to regional lymph nodes
and distant organs [8,13,14]. Treatment strategies for pri-
mary eyelid sebaceous carcinoma are surgery, radiother-
apy, and chemotherapy [15-17]. Distant hematogenous
metastases to the lung, liver, and brain have a mortality
rate as high as 30% [16,18]. However, few reports demon-
strated the surgical treatment of metastatic eyelid seba-
ceous carcinoma.
Standard treatment strategy for pulmonary metastatic
sebaceous carcinoma has not yet been established be-
cause of the limited number of cases. Chemotherapy
regimens in existing reports are largely based on the
combination regimens commonly used in the treatment
of other forms of poorly differentiated carcinomas of the
head and neck region [19,20]. Husain et al. reported
combined chemotherapy of carboplatin and docetaxel
for the patient who had multiple lung and lymph node
metastases, which resulted in a 30% decrease in tumor
size, but the efficacy of this regimen for sebaceous carcin-
oma has not yet been fully evaluated [21]. Radiotherapy
for primary eyelid sebaceous carcinoma was described in
several reports; however, there have been no reports de-
scribing radiotherapy for pulmonary metastatic eyelid
sebaceous carcinoma [22,23]. Resection of pulmonary
metastases in patients with sebaceous carcinoma is con-
troversial. However, our case suggests that a surgical ap-
proach to lung metastasis of eyelid sebaceous carcinoma
could prolong survival in certain subgroups of patients,
namely, those with a limited number of metastatic nodules
or a significant disease-free interval.
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carcinoma or primary lung cancer cannot be predicted
only on the basis of radiologic findings or disease-free
interval. In the present case, we could successfully differ-
entiate solitary lung metastasis of eyelid sebaceous car-
cinoma from primary lung cancer using oil red O stain,
which stains lipid has a red color, on frozen sections.
Conclusion
We report a rare case of solitary lung metastasis of eye-
lid sebaceous carcinoma, which was successfully resected
and differentiated from primary lung cancer using oil
red O stain on frozen sections. Pulmonary resection is a
good option for the treatment and diagnosis of meta-
static eyelid sebaceous carcinoma.
Consent
Written informed consent was obtained from the patient
for the publication of this case presentation and accom-
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